002603:SZSEShijiazhuang Yiling Pharmaceutical Co., Ltd. Class A Analysis

Shijiazhuang Yiling Pharmaceutical Co., Ltd. trades at ¥15.38, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 8.0%. Relative strength is 39.5 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at ¥15.08 up to resistance at ¥17.47.
The shares look undervalued, trading on 18.8 times earnings below a sector average of 29.5. Sell-side targets cluster 35.6% above the current quote. Revenue is contracting at 2.8% on a 17.5% profit margin. The 5.27% dividend yield looks stretched against payout coverage.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 32.9%, a beta of 0.21 and a maximum drawdown of 30.4%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.